(86) KUEPPERS. F., BLACK, L. Alpha-1-antitrypsin and its deficiency. American Review of Respiratory Disease 110: 176194,1974. (87) KUEPPERS, F., FALLAT, R., LARSON, R.K. Obstructive lung disease and alpha-1-antitrypsin deficiency gene heterozygosity. Science 165: 399-9661969. (88) LARSON, R.K., BARMAN, M.L. The familial occurrence of chronic obstructive pulmonary disease. Annals of Internal Medicine 63(6): 1691-1663, December 1965. (89) LARSON, R.K., BARMAN, M.L. KUEPPERS, F., FUDENBERG, H.H. Genetic and environmental determinants of chronic obstructive pulmonary disease. Annals of Internal Medicine 72(5): 627-632, May 1970. (90) LEBOWITZ, M.D., BURROWS, B. Quantitative relationshipe between cigarette smoking and chronic productive cough. International Journal of Epidemiology 6(2): 197-113,1977. (91) LEUCHTENBERGER, C., LEUCHTENBERGER, R., DOOLIN, R. A correlated histological, cytological and cytochemical study of the tracheobronchial tree and lungs of mice exposed to cigarette smoke. 1. Bronchitis with atypical epithelial changes in mice exposed to cigarette smoke. Cancer 11: 496-566, 19.58. (96) LIEBERMAN, J., GAWAD, M.A. Inhibitors and activators of leukocytic proteases in purulent sputum: Digestion of human lung and inhibition of alpha-1-antitrypsin. Journal of Laboratory and ClinicaI Medicine 77(4): 713- 727,197l. (98) LIEBERMAN, J., MITTMAN, C., SCHNEIDER, A.S. Screening for homozy- gous and heterozygous alpha-1-antitrypsin deficiency. Journal of the American Medical Association 210: 20552966,1969. (94) LOW, R.B. Effect of a phagocytic load on macrophage protein and nucleic acid biosynthesis. Journal of Cell Biology 67: 24&a, 1975. (Abstract) (95) LOW, RB. Protein biosynthesis by the pulmonary alveolar macrophage: Comparison of suspended and adhered cells. American Review of Respiratory Disease 109(4): 741,1974. (Abstract) (96) LOW, R.B., BULMAN, C.A. Substrate transport by the pulmonary alveolar macrophage. Effects of cigarette smoke. American Review of Respiratory Disease 116: 423-431,1977. (87) MACKLEM, P.T., MEAD, J. Resistance of central and peripheral airways measured by a retrograde catheter. Journal of Applied Physiology 22(l): 395 461,1967. (98) MANFREDA, J., NELSON, N., CHERNIACK, R.M. Prevalence of respiratory abnormalities in a rural and an urban community. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, Division of Lung Disease. National Technical Information Service, PB 272 154, September 1,1977, pp. 4266. (99) MANFREDA, J., NELSON, N., CHERNIACK, R.M. Prevalence of respiratory abnormalities in a rural and an urban community. American Review of Respiratory Disease 117: 215-226,1978. (100) MANFREDA, J., NELSON, N., CHERNIACK, RM. Two year followup: The general population of Charleswood and Portage La Praiie. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, Division of Lung Diseases. National Technical Information Service, PB 272 154, September 1, 1977, pp. 97-165. (101) MARCO, V., MASS, B., MERANZE, D.R., WEINBAUM, G., KIMBEL, P. Induction of experimental emphysema in dogs using leukocyte homogenates. American Review of Respiratory Disease 164: 595-5931971. 6--48 (206) MARCO, M., MINETTE, A. Lung function changes in smokers with normal conventional spirometry. American Review of Respiratory Disease 114: 723- X38,1976. (10s) MASS, B., IKEDA, I'.. MERANZE, DR., WEINBAUM, G., KIMBEL, P. Induction of experimental emphysema: Cellular and species specificity. American Review of Respiratory Disease 166: 384391.1972. (104) MATULIONIS, D.H., TRAURIG, H.H. In situ response of lung macrophages and hydrolase activities in cigarette smoke. Laboratory Investigation 37(3): 314-326,1977. (XX) MCCARTHY, D.S., CRAIG, D.B., CHERNIACK, R.M. Effect of modification of the smoking habit on lung function. American Review of Respiratory Disease 114: 163-113,1976. (106) MILLER, R., KUEPPERS, S.F., HEPPER, N.G. A comprehensive study of host factom for chronic obstructive pulmonary disease in a North American rural community: Genetic characteristics. Bulletin of the International Union Against Tuberculosis 51(1, Tome 2): 629,1976. (107) MITCHELL, R.S., STANFORD, R.E., JOHNSON, J.M., SILVERS, G.W., DART, G., GEORGE, M.S. The morphologic features of the bronchi, bronchioles and alveoli in chronic airway obstruction: A clinicopathologic study. American Review of Respiratory Disease 114(l): 137-145, July 1976. (108) MITTMAN, C. The PiMZ phenotype: Is it a significant risk factor for the development of chronic obstructive lung disease? American Review of Respiratory Disease 118: 649652,1978. (109) MITTMAN, C. (Editor). Pulmonary emphysema and proteolysis. New York, Academic Press, 1972,562 pp. (110) MONTO, A.S., HIGGINS, M.W., ROSS, H.W. The Tecumseh Study of respiratory illness. VIII. Acute infection in chronic respiratory disease and comparison groups. American Beview of Respiratory Disease 111(l): 27-36, January 1975. (111) MORSE, J.O., LEBOWITZ, M.D., KNUDSON, R.J., BURROWS, B. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. New England Journal of Medicine 296(21): 119&1194,1977. (112) NIEWOEHNER, D.E., KLEINERMAN, J., RICE, D.B. Pathologic changes in the peripheral airways of young cigarette smokers. New England Journal of Medicine WI: 755758.1974. (118) OSHIMA, H., IMAI, M., KAWAGISHI, T. A study on air pollution effects on the respiratory symptoms in the city of Yokkaichi, Central Japan. Mie Igaku 16(l): 25-W, June 1972. (114) OXHOJ, H., BAKE, B., WILHELMSEN, L. Ability of spirometry, low-volume curves, and the nitrogen closing volume test to detect smokers. Scandinavian Journal of Respiratory Disease 58: 8O-96,1977. (115) PETERSON, D.I., LONERGAN, L.H., HARDINGE, M.G. Smoking and pulmonary function. Archives of Environmental HeaIth 16: 2X-218,1968. (116) PRATT, S.A., FINLEY, T.N., SMITH, M.H., LADMAN, A.J. A comparison of alveolar macrophages and pulmonary surfactant (7) obtained from the lungs of human smokers and nonsmoker by endobronchial lavage. Anatomical Record X3(4): 49%508,1969. (If?) Prevalence of selected chronic respiratory conditions, United Stateg1970. DHEW Publication No. (HRA) 741511,1973, Series 10, No. 84. (118) The Registrar General's Decennial Supplement, England and Wales, Occupa- tional Mortality. 1931, Her Majesty's Stationery Office, London, 1951. (119) RODRIGUEZ, R.J., WHITE, RR., SENIOR, R.M., LEVINE, E.A. ~b+stase release from human alveolar macrophages: Comparison between smokers and nonsmokers. Science 198(4314): 313-314,1977. 649 I (1%)) ROSZMAN, T.L., ELLIOTT, L.H., ROGERS, A.S. Suppression of lymphocyte function by products derived from cigarette smoke. American Review of Respiratory Disease ill(4): 453-457,1975. (IZf) ROSZMAN, T.L., ROGERS, AS. The immunosuppressive potential of products derived from cigarette smoke. American Review of Respiratory Disease 163: 1153-1163.1973. (f.t?Z) RUSH, D. Changes in respiratory symptoms related to smoking in a teenage population: The results of two linked surveys separated by one year. International Journal of Epidemiology 5(2): 1731731976. (I%?) RUSH, D. Respiratory symptoms in a group of American secondary school students: The overwhelming association with cigarette smoking. International Journal of Epidemiology 3(2): 153-X5,1974. (f.%j) RYLANDER, R. Pulmonary cell responses to inhaled cigarette smoke. Archives of Environmental Health 29: 329333,1974. (1%) SAWICKI, F. Air pollution and prevalence of chronic nonspecific respiratory diseases. In: Brzezinski, Z., Kopczynski, J., Sawicki, F. (Editors). Ecology of Chronic Nonspecific Respiratory Diseases. International Symposium, Septem- ber 7-3, 1971, Warsaw, Poland, Panstwowy Zaklad Wydawnictw Lekarskich, 1972, pp. 3-13. (f.26) SCHUYLER, MR., RYNBRANDT, D:J., KLEINERIKAN, J. Physiologic and morphologic observations of the effecta of intravenous elastase on the lung. American Review of Respiratory Disease 117: 97-192,1978. (1%") SEELY, J.E., ZUSKIN, E., BOUHUYS, A. Cigarette smoking: Objective evidence for lung damage in teen-agers. Science 172: 741-743,197l. (1.28) SELTZER, C.C., SIEGELAUB, A.B., FRIEDMAN, G.D., COLLEN, M.F. Differences in pulmonary function related to smoking habits and race. American Review of Respiratory Dii llo(5): 593-693, November 1974. (1.68) SENIOR, R.M., TEGNER, H., KUHN, C., OHLSSON, K., STARCHER, B.G., PIERCE, J.A. The induction of pulmonary emphysema wit41 human leukocyte elastase. American Review of Respiratory Dii 116: 469-475,1977. (190) SHEA, J.W;, HUBER, G.L., HOLMES, L., NOMANS, S.A. The effect of experimental tobacco smoke inhalation on in vitro alveolar macrophage bactericidal function. Journal of Laboratory and Clinical Medicine 9q2): 276 282,1973. (181) SILVERMAN, N.A., POTVIN, C., ALEXANDER, J.C., JR., CHRETIEN, P.B. In vitro lymphocyte reactivity and T-cell levels in chronic cigarette smokers. Clinical and Experimental Immunity 22(2): 285-292, November 1975. (rs2j SNIDER, G.I., HAYES, J.A., FRANZBLAU, c., KAGAN; H.M., STONE, P.s., NORTHY, A.L. Relationship between elastolytic activity and experimental emphysema-inducing properties or papain preparations. American Review of Respiratory Disease 110:~~262,1974. (139) STEBBINGS, J.H., JR. A survey of respiratory disease among New York City postal and transit workers. IV. Racial differences in the FEVi. Environmental Research 6: 147-1531973. (284) STERLING, G.M. Mechanism of bronchoconstriction caused by cigarette smoking. British Medical Journal 3: 275-277, July W,l967. (135) STUART, R.S., HIGGINS, W.H., BROWN, P.W. In vitro toxicity of tobacco smoke solutions to rabbit alveolar macrophagea. Archives of Environmental .HeaIth 33: 1351461978. (136) TALAMO, R.C., ALLEN, J.D., KAHAN, M.G., AUSTEN, `K.F. Hereditary alpha-I-antitrypsin deficiency. New England Journal of Medicine 273(7): 345 351, February 15,1963. (187') THOMAS, W.R., HOLT, P.G., KEAST, D. Cigarette smoke and phagocyte function: Effect-of chronic. exposure in- vivo and acute exposure in vitro. Infection and Immunity 29(2): 463-475,1978. 6-50 (fS8) THURLBECK, W.M. Aspects of chronic airflow obstruction. Chest 72: 341-349, 1977. (fS9) THURLBECK, W.M. Chronic airflow obstruction in lung disease. V. Major problems in pathology. Philadelphia, W.B. Saunders Co., 1976, pp. 235-287. (f&l) THURLBECK, W.M. Small airways: Physiology meets pathology. New England Journal of Medicine 298: 131&1311,1978. (141) U.S. PUBLIC HEALTH SERVICE. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control. PHS Publication No. 1193,1964,387 pp. (f&J U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking. A Public Health Service Review: 1967. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration, DHEW Publication No. 1696, Revised, January 1968,227 pp. (149) U.S. PUBLIC HEALTH SERVICE The Health Consequences of Smoking, 1968. Supplement to the 1967 Public Health Service Review. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration. DHEW Publication No. 1696, 1963, 117 pp. (144) U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking, 1969. Supplement to the 1967 Public Health Service Review. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration. DHEW Publication No. 1969-2, 1969, 98 pp. (1.45) U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking. A Report of the Surgeon General: 1971. U.S. Department of Health, Education, and Welfare, Health Services and Mental Health Administration. DHEW Publication No. (HSM) 71-7513,1971,458 pp. (116) U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking. A Report of the Surgeon General: 1972. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration. DHEW Publication No. (HSM) 727516,1972,158 pp. (24r) U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking: 1973. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration. DHEW Publica- tion No. (HSM) 73-8764.1973.249 pp. (14s) U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking: 1974. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration. DHEW Publica- tion No. (CDC) 748764,1974, I24 pp. (149) U.S. PUBLIC HEALTH SERVICE. The Health Consequences of Smoking: 1975. U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration. DHEW Publica- tion No. (CDC) 7687@4,1975,235 pp. (150) VAN DER LENDE, R., DE KROCJN, J.P.M., TAMMELING, G.J., VISSER, B.F., DE VRIES, K., WEVERHESS, J., ORIE, N.G.M. Prevalence of chronic nonspecific lung disease in a nonpolluted and in air-polluted area of the Netherlands. In: Brzezinski, Z., Kopczynski, J., Sawicki, F. (Editors). Ecology of Chronic Nonspecific Respiratory Diseases. International Symposium, September 7-8, 1971, Warsaw, Poland, Panstwowy Zaklad Wydawnictw Lekarskich, 1972, pp. 2133. (151) WALDMAN, RH., BOND, J.O., LEVI'PI', L.P. HARTWIG, E.C., PRATHER, R.L., BARATTA-NEILL, J.S., SMALL, P.A., JR An evaluation of infhrenza immunization. Influence of route of administration and vaccine strain. Bulletin of the World Health Organization 41: 543&I&1969. (15.6) WANNER, A. State of the art Clinical aspects of mucociliary transport. American Review of Respiratory Disease 116: 73-125.1977. 6-51 (153) WANNER, A., HIRSCH, J.A., GREENELTER, D.E., SWENSON, E.W., FORE, T. Tracheal mucous velocity in beagles after chronic exposure to cigarette smoke. Archives of Environmental Health 2'7:379-371,1973. (254) WARR, G.A., MARTIN, R.R. In vitro migration of human alveolar macro- phages: Effects of cigarette smoking. Infection and Immunity S(2): 222-227, 1973. (155) WARR, G.A., MARTIN, RR., HOLLEMAN, C.L., CRISWELL, B.S. Classifica- tion of bronchial lymphocytes from nonsmokers and smokers. American Review of Respiratory Disease 113: 96-106,1976. (156) WARR, G.A., MARTIN, RR., SHARP, P.M., ROSSEN, R.D. Normal human bronchial immunoglobulins and proteins. American Review of Respiratory Disease 116: 25-36,1977. (157) WEISSMANN, G. The role of lysosomea in inflammation and disease. Annual Review of Medicine 18: 97-ll2,1967. (258) WELCH, M.H., REINECKE, M.E. HAMMERSTEN, J.F., GUENTER, C.A. Antitrypsin deficiency in pulmonary dii: The significance of intermediate levels. Annals of Internal Medicine 71(3): 553542. September 1969. (159) WILHELMSEN, L. Effects on bronchopulmonary symptoms, ventilation, and lung mechanics of abstinence from tobacco smoking. Scandanavian Journal of Respiratory Disease 48: 467414,1967. (I 60) WOOLCOCK, A.J., VINCENT, NJ., MACKLEM, P.T. Frequency dependence of compliance as a test for obstruction of the small airways. Journal of Clinicai Investigation 48: 1097-1165,1969. (I 61) WOOLF, CR. Clinical findings, sputum examinations, and pulmonary function tests related to the smoking habit of 566 women. Chest 66: 653659, 1974. (166) WYATT, J.P. Environmental factors in chronic lung disease. In: Lee, D.H.K. (Editor). Environmental Factors on Respiratory Disease. Fogarty Intemation- al Center Proceedings No. 11, New York, Academic Press, 1972, pp. 119137. (Abstract) (I64 YEAGER, H. Alveolar cells: Depressan t effect of cigarette smoke on protein synthesis. proceedings of the society of Experimental Biology and Medicine 31(l): 247~259,1969. (f64) YEAGER H., ZIMMET, S.M., SCHWARTZ, S.L. Pinocytosis by human alveolar macrophages: Comparison of smokers and nonsmokers. Journal of Clinical Investigation 54(2): 247~251,1974. 6-52 7. INTERACTION BETWEEN SMOKING AND OCCUPATIONAL EXPOSURES. National Institute for Occupational Safety and Health CONTENTS Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..,. . . . . . . . . . . . . . . . . . . . . . . . 5 Illustrative Examples of Different Modes of Action Between Smoking and Occupational Exposures ............. 5 Tobacco F'roducts May Serve as Vectors by Becoming Contaminated with Toxic Agents Found in the Workplace, Thus Facilitating Entry of the Agent by Inhalation, Ingestion, and/or Skin Absorption ........ 5 Workplace Chemicals May Be Transformed Into More Harmful Agents by Smoking.. ............................. 5 Certain Toxic Agents in Tobacco F'roducts and/or Smoke May Also Occur in the Workplace, Thus Increasing Exposure to the Agent.. ...................... 7 Hydrogen Cyanide ......................................... 7 Carbon Monoxide ........................................... 8 Methylene Chloride ........................................ 8 Other Chemical Agents.. ................................. 9 Smoking May Contribute to an Effect Comparable to That Which Can Result From Exposure to Toxic Agents Found in the Workplace, Thus Causing an Additive Biological Effect.. ................................. 9 Coal Dust.. ................................................... 9 Cotton Dust.. ................................................ 9 Beta-Radiation .............................................. 10 Chlorine.. ................................................... .10 Exposure Among Fire Fighters.. ..................... 10 Smoking May Act Synergistically with Toxic Agents Found in the Workplace to Cause a Much More Profound Effect Than That Anticipated Simply From the Separate Influences of the Agent and Smoking Added Together ................................... 11 Asbestos ...................................................... 11 Exposures in the Rubber Industry.. ................ .13 Radon Daughters ......................................... .14 Exposure in Gold Mining.. ............................ .15 Smoking May Contribute to Accidents in the Workplace ....................................................... 15 7-3 Examples Where Action Between Smoking and Occupational Exposure Has Been Suggested or Only Hypothesized . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Cadmium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Chloromethyl Ether . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Beta-Naphthylamine and Other Aromatic Amines . . ., . . . . . . . . . . . . .._.. . . . . . . , . . . . . . . . . . . . . . . . .,. . . . . . 16 Trends in Smoking Habits and in Morbidity and Mortality Bates for Various Occupational Groups . . . . . . . . . . . . . . . . . . . . . . 1'7 Summary and Recommendations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 Recommendations for Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 LIST OF FIGURES Figure 1. -Respiratory cancer rates among uranium miners by cigarette usage and radiation exposure compared with rates among nonminers . . . . . . . . . . . . . . . . . . . . . . 14 7-4 Introduction Despite increasing recognition that both smoking and occupational exposures contribute independently to the development of certain disease states, few investigators have addressed the ways in which these two factors act together to produce disease. Some of the effects historically attributed to smoking may actually reflect an interaction between smoking and occupational exposure. This cannot always be quantified at the present time, but at least six different ways have been identified in which smoking may act with physical and chemical agents found in the workplace. These actions are not mutually exclusive and several may prevail for any given agent. Six ways in which smoking may act with physical and chemical agents to produce or increase adverse health effects are: 1. Tobacco products may serve as vectors by becoming contaminated with toxic agents found in the workplace, thus facilitating entry of the agent by inhalation, ingestion, and/or skin absorption. 2. Workplace chemicals may be transformed into more harmful agents by smoking. 3. Certain toxic agents in tobacco products and/or smoke may also occur in the workplace, thus increasing exposure to the agent. 4. Smoking may contribute to an effect comparable to that which can result from exposure to toxic agents found in the workplace, thus causing an additive biological effect. 5. Smoking may act synergistically with toxic agents found in the workplace to cause a much more profound effect than that anticipated simply from the separate influences of the agent and smoking added together. 6. Smoking may contribute to accidents in the workplace. Exposure to multiple physical and chemical agents in the workplace can compound these various types of actions. illustrative Examples of Different Modes of Action Between gmoklng and Occupational Exposures Tobacco products may serve as vectors by becoming contaminated with toxic agents found in the workplace, thus facilitating entry of the agent by inhalation, ingestion, and/or skin absorption. Workplace chemicals may be transformed into more harmful agents by smoking. Investigations of outbreaks of polymer fume fever provide clear illustrations of both of these modes of action. Polymer fume fever is a disease with influenza-like symptoms caused by inhalation of fumes from heated polytetrafluoroethylene, e.g., Teflon@ (59). Typical symptoms include chest discomfort, fever, leukocytosis, headache, chills, muscular aches, and weakness. Since the symptoms are SO similar to influenza, polymer fume fever may be difficult to diagnose. 7-5 Workers who continue to smoke may experience continuing reexposure and recurrent symptoms. Although complete recovery has been reported to occur usually within 12 to 48 hours after exposure is terminated, an autopsy report has attributed permanent lung damage to repeated episodes of polymer fume fever (89). Pulmonary edema following exposure to heated polytetrafluoroethylene has also been reported (26, 73). Polymer fume fever was first recorded in 1951(38) as a result of two workers being exposed to the fluorocarbon polymer, polytetrafluoroethylene, heated to 450-500" C. The particular decompo- sition product(s) responsible for polymer fume fever have not yet been identified, but temperatures in excess of 315" C have been sufficient to cause symptoms. The temperature of the combustion zone of cigarettes is approximately 875" C (82). Numerous outbreaks of polymer fume fever among smokers have been attributed to the decomposition of workplace polytetrafluoroe- thylene by lit cigarettes and inhalation of the harmful decomposition products with cigarette smoke. One report (18) describes aviation employees whose work involved contact with door seals that had been sprayed with an unspecified fluorocarbon polymer. In one case, a worker smoking during a break realized by the taste of his cigarette that it had become contaminated. Although the worker extinguished' the cigarette, he experienced shivering and chills, which lasted approximately 6 hours, beginning l/2 hour after this incident. Another illustrative report (12) describes outbreaks of polymer fume fever among workers who smoked when their hands were contaminated with polytetrafluoroethylene used as a mold release agent. There was no recurrence of symptoms after smoking at the plant was prohibited. An outbreak of polymer fume fever among workers using liquid fluorocar- bon polymer in the production of imitation crushed velvet was likewise attributed to decomposition of fluorocarbon polymer by lit cigarettes (85). Processing temperatures at this plant were too low to pyrolyze the polymer. The seven affected workers were all cigarette smokers, whereas most of the workers without symptoms were nonsmokers. After work practices were changed to prohibit smoking in the work area and to require hand washing before smoking, no further symptoms at this facility were reported. Other outbreaks of polymer fume fever attributed to cigarette smoking have also been reported (I, 11, 44, 76 90). The effects of smoking cigarettes contaminated with known amounts of tetrafluoroethylene polymer have been studied with the assistance of human volunteers (22). Nine out of ten subjects were reported to exhibit typical polymer fume fever symptoms after each had smoked just one cigarette contaminated with 0.46 mg tetrafluoro- ethylene polymer. Onset of symptoms ranged from 1 to 3.5 hours after smoking; recovery time averaged 9 hours. 7-6 With respect, to tobacco products serving as vectors, the National Institute for Occupational Safety and Health (NIOSH) has thus far identified the following agents as potential occupational contaminants of tobacco and tobacco products: Agent Formaldehyde (61) Boron Trifluoride (57) Organotin (66) Methyl Parathion (65) Dinitro-otiho-Creosol (60) Carbaryl (58) Inorganic Fluorides (63) Inorganic Mercury (64) Lead (81, 94) &fajor Health &jFfecf.s Respiratory irritant, dermatitis Respiratory irritant, joint dis- &iSC? Respiratory irritant Reduced erythrocyte cholinester- ase activity Kidney damage, peripheral neu- ritis, CNS disturbances. Inhibition of acetylcholinesterase Fluoride osteosclerosis CNS disturbances, kidney dam- age, peripheral neuritis Servous system toxin, renal toxin, changes in hematopoiet- ic system Additional research is clearly warranted to identify other workplace chemicals which are transformed into more toxic agents by tobacco smoking. Certain toxic agents in tobacco products and/or smoke may also occur in the workplace, thus increasing exposure to the agent. Hydrogen Cyanide Hydrogen cyanide has been found in cigarette smoke at concentrations as high as 1,600 ppm (83). In 1973 Pettigrew and Fell (69) found the plasma thiocyanate (a metabolite of cyanide) levels of smokers significantly elevated as compared to those in nonsmokers. In 1973 Radojicic (71) reported a study of 43 workers in the electroplating division of an electronics firm in Nes, Yugoslavia. He found that the majority of workers exposed to cyanide complained of fatigue, headache, asthenia, tremors of the hands and feet, and pain and nausea. The urinary thiocyanate concentrations of the exposed group of workers were higher at the end of the work shift than before exposure at work. Urinary thiocyanate concentrations were signifi- cantly higher among exposed smokers than unexposed smoking controls, significantly higher among exposed nonsmokers than unex- posed nonsmokers, and significantly higher among exposed smokers than among exposed nonsmokers. These findings demonstrate that smoking and occupational exposure can each contribute to a worker's total exposure to and intake of cyanide. 7-7 Adverse effects from cyanide may occur from sublethal doses. Hydrogen cyanide and cyanide salts inhibit cytochrome oxidase. Cyanide can form complexes with heavy metal ions. Formations of these complexes in the body can rapidly cause disturbances in enzyme systems in which heavy metals act as co-factors either alone or as part of organic molecules (2, 15, 27). Thiocyanate itself has toxic effects, especially inhibition of uptake of inorganic iodide into the thyroid gland for incorporation into thyroxin (91). The National Institute for Occupational Safety and Health has estimated that over 20,000 workers in 75 different occupational groups have potential occupation- al exposure to cyanide (62). Cigarette smoking causes increased exposure to carbon monoxide (CO). A CO concentration of 4 percent (40,000 ppm) in cigarette smoke leads to an alveolar CO concentration of 0.04 to 0.05 percent (400 to 500 ppm), which produces a carboxyhemoglobin (COHb) concentration of 3 to 10 percent (21, 40, 68). Goldsmith, et al. (29) estimated that the cigarette smoker is exposed to 475 ppm CO for approximately 6 minutes per cigarette. In a study of COHb levels in British steelworkers, Jones and Walters (39) found a 4.9 percent end of shift COHb saturation in nonsmoking blast furnace workers compared to 1.5 percent saturation in non- smoking unexposed controls. For heavy cigarette smokers, the levels were 7.4 percent for blast furnace workers and 4.0 percent for smoking unexposed controls. The COHb levels of blast furnace workers who smoked were in a critical range. Studies by Aronow (5-g), Anderson (3), and Horvat (36) and their associates have shown that levels of COHb in excess of 5 percent can cause cardiovascular alterations which are dangerous for persons with cardiovascular disease. Potential occupational exposure to CO is common (37). Since a significant number of workers have coronary heart disease and many smoke, additional occupational exposure to CO may increase eardiovas- cular morbidity and mortality. Methylene Chloride Methylene chloride is metabolized to CO in the body (28). COHb levels in blood increase with increasing environmental concentrations of methylene chloride as well as with increasing physical activity at the time of exposure (10, 80). Maximum COHb levels occur 3 to 4 hours after exposure is discontinued. Mean methylene chloride concentrations of 778 ppm over a 3-hour exposure period produced a maximum COHb level of 9.1 percent 4 hours after exposure was discontinued. Twenty hours after this 7-8 exposure the COHb level remained elevated (4.4 percent versus 0.8 percent prior to exposure) (80). Baaed on this time lag, prohibiting a worker exposed to methylene chloride from smoking on the job would not be sufficient to protect the worker who smokes after he leaves work from the additive burdens of CO from methylene chloride and tobacco smoke. Other Chemical Agents Other chemical agents found in tobacco, or in the combustion of tobacco products, and also.potentially found in the workplace include: acetone, acrolein, aldehydes, arsenic, cadmium, formaldehyde, hydro- gen sulfide, ketones, lead, methyl nitrite, nicotine, nitrogen dioxide, phenol, and polycyclic compounds (83). Smoking may contribute to an effect comparable to that which can result from exposure to toxic agents found in the workplace, thus causing an additive biological effect. Coal Dust Coal dust and cigarette smoking appear to act in an additive fashion to produce obstructive airway disease. Although dust exposure alone plays a significant role in the development of this disease, there is a significantly higher prevalence of obstructive airway disease in smoking miners than in nonsmoking miners with the same dust exposure (41). Flow volume curve data suggest that nonsmoking miners with dust-induced chronic obstructive airway disease have decreased flow rates primarily at higher lung volumes, whereas smoking miners have decreased flow rates at all lung volumes (32). cotton Dust Many investigators have noted that among cotton workers, cigarette smokers show increased prevalence of byssinosis when compared to nonsmoking cotton workers (13, 53, 54, 55). Cotton dust inhalation produces an acute clinical syndrome consisting of chest tightness, cough, and shortness of breath in cotton workers (34). This was formerly known as "Monday morning fever" since symptoms develop on the first day of work after an absence. The clinical syndrome may be accompanied by significant reduction in pulmonary function (52). The acute clinical and functional abnormalities produced by cotton dust gradually become more frequent as the disease progresses, eventually resulting in chronic obstructive airways disease (34). In the acute phase of the illness there is a significantly greater diminution in pulmonary function in smokers than in nonsmokers (55), and the relationship of cotton dust and smoking to pulmonary dysfunction appears to be additive. 7-9 In the more severe phave of chronic obstructive airway disease, the relationship between smoking and cotton dust exposure appears to be synergistic (5.5). Beta-Radiatim In studies in mice when both beta-radiation and cigarette tar were applied to produce carcinomas in the skin, cancers appeared 6 to 7 months earlier than when radiation was administered alone. The shortened latent period gave an illusion of synergism which was reported in a preliminary analysis based on tumor yield at 18 months. However, at the conclusion of the experiment, the authors felt there was actually nothing more than an additive biological effect of cigarette tar and beta-radiation (23). Chlorine Exposure to chlorine and cigarette smoke may cause an additive biological effect. Chester, et al. (20) examined 139 men in a plant producing chlorine and sodium hydroxide by electrolysis of brine. Of the 139 workers, 55 had been accidentally exposed one or more times to chlorine at high concentrations and had required oxygen therapy at least once during their employment. The maximal mid-expiratory flow (MMF) values of workers with accidental chlorine exposure was compared with those of nonexposed workers for smokers and nonsmokers. A significant difference in MMF was seen when chlorine and smoking were considered as additive@xic agents. MMF values decrease in the sequence from unexposed nonsmokers (4.36) to unexposed smokers (4.13) to exposed nonsmokers (4.10) and to exposed smokers (3.57). Capodaglio, et al. (19) studied the diffusing capacity of the lung in workers employed in a plant for electrolytic production of chlorine and soda. He compared 52 exposed workers to 2'7 unexposed workers. The diffusing capacity of the lung was significantly lower in exposed smokers than in nonexposed smokers (Prectit~~;~)at.i*:~ iti ! he, h:d for smoking, irritation of the eyes, and cough !/;:i. Smoking can also contribute to fire ant1 cxlda4ons in occupational settings where inflamma% and t>sltLisive c&mical ag